
Join to View Full Profile
5415 W Cedar LnSuite 204bBethesda, MD 20814
Phone+1 301-605-5902
Fax+1 301-405-1561
Dr. Gold is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Philip Gold, MD, is a psychiatrist based in Bethesda, MD. He completed his internship in Internal Medicine at Boston University Medical Center (1970-1971) and a Psychiatry residency at Brigham and Women's Hospital/Harvard Medical School (1971-1974) after earning his medical degree at Duke University School of Medicine in 1970. Dr. Gold has contributed to the field through various publications, including recent articles on stress neuroendocrinology, antidepressants, and the therapeutic potential of ketamine, some of which have been cited multiple times in other scientific works.
Education & Training
- Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Psychiatry, 1971 - 1974
- Boston University Medical CenterInternship, Internal Medicine, 1970 - 1971
- Duke University School of MedicineClass of 1970
Certifications & Licensure
- MD State Medical License 1975 - 2026
- VA State Medical License 2009 - 2022
- DC State Medical License 1980 - 2013
- NC State Medical License 1971 - 1999
- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- The neuroendocrinology of stress and the importance of a proper balance between the mineralocorticoid and glucocorticoid receptors.Philip W Gold, Ma-Li Wong
Molecular Psychiatry. 2025-01-01 - Comment on: Antidepressants act by directly binding to TRKB neurotrophin receptors.Philip W Gold, Ma-Li Wong
Molecular Psychiatry. 2024-12-01 - 25 citationsInflammation, stress and depression: An exploration of ketamine's therapeutic profile.Jenessa N Johnston, Maximillian S Greenwald, Ioline D Henter, Christoph Kraus, Anahit Mkrtchian
Drug Discovery Today. 2023-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: